Immuno-Oncology
The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.
Latest News
Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC
Chemoimmunotherapy Shows Promise for Limited-Stage SCLC in Real-World Study
Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy
From “Super Skeptical” Beginnings, a New Immune-Modulatory Vaccine Awaits Phase 3 Results
Insurance Delays Add Costs to CAR T-Cell Therapy: Ravi Vij, MD, MBA
Weighing Relapse Risk Against Benefit in Advanced NSCLC Immunotherapy: Jonathan Thompson, MD, MS
CAR T and Bispecifics Pose Different Challenges in Blood Cancer Treatment: Ravi Vij, MD, MBA
The Pharmacist’s Role in Value-Based Oncology Models: David Awad, PharmD, BCOP
Documentation, Collaboration Are Key to Managing Toxicities: David Awad, PharmD, BCOP
Pharmacists Essential to Expanding CAR T, Bispecific Access: David Awad, PharmD, BCOP
Dr Guru Sonpavde on the Potential of Nivolumab Plus Chemotherapy in Urothelial Carcinoma
Dr Erin Gillaspie Explains the Role of Immunotherapies in Lung Cancer Treatment
Dr Sigrun Hallmeyer: Precision Medicine Needs to Become More Efficient
Dr Jennifer Choe Discusses Head and Neck Cancer Relapse, New Treatment Trials, Promising Responses
Podcast: This Week in Managed Care—Step Therapy in Medicare Advantage and Other Health News
Addressing Financial Toxicity With Navigators and Better Conversations Around Decision Making
Podcast: This Week in Managed Care—Bringing Down Health Insurance Premiums and Other Health News
More News
The Challenge With CAR T? It’s Not the Drug, It’s the Delivery
